FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087124500> ?p ?o ?g. }

• W3087124500 endingPage "1249" @default.
• W3087124500 startingPage "1242" @default.
• W3087124500 abstract "Background Peptide receptor radionuclide therapy and selective internal radiation therapy are effective radionuclide therapy modalities for unresectable metastatic neuroendocrine tumor patients that cannot be controlled with somatostatin analogs. The present study is intended to evaluate the therapeutic efficacy and toxicity of the combined therapy of selective internal radiation therapy and peptide receptor radionuclide therapy and stand-alone selective internal radiation therapy in patients with neuroendocrine tumor, a liver-dominant disease. Methods This cohort consists of 27 patients with metastatic neuroendocrine tumor and liver-dominant disease. They were grouped as the patients who were treated with selective internal radiation therapy for unresectable liver metastasis (n = 15) and the patients who received a combination of selective internal radiation therapy and peptide receptor radionuclide therapy (n = 12) for hepatic and extrahepatic metastasis. Treatment efficacy and treatment-associated toxicity were retrospectively assessed in both groups. Results The objective treatment response and stable disease were found in 13 patients (86.6%) in the selective internal radiation therapy group and eight patients (66.6%) in the selective internal radiation therapy + peptide receptor radionuclide therapy group. The median overall survival rate was found to be 34.9 months, in the selective internal radiation therapy group and 67.5 months in the selective internal radiation therapy + peptide receptor radionuclide therapy group ( P = 0.217). The median progression-free survival data was not reached, and the mean values of progression-free survival were 53.1 ± 9.9 months in the selective internal radiation therapy group, and 27.2 ± 5.9 months in the selective internal radiation therapy + peptide receptor radionuclide therapy group ( P = 0.561). Temporary lymphopenia was the most common side effect. Grade 1–2 hepatotoxicity was observed to be 6.6% in the selective internal radiation therapy group, while it was not observed in selective internal radiation therapy + peptide receptor radionuclide therapy group. Conclusions In the neuroendocrine tumors with liver-dominant metastatic disease, personalized selective internal radiation therapy and peptide receptor radionuclide therapy and their combinations result in increased survival rates. Selective internal radiation therapy alone could be an effective treatment in patients with liver-limited and -dominant disease." @default.
• W3087124500 created "2020-09-25" @default.
• W3087124500 creator A5011386737 @default.
• W3087124500 creator A5018467007 @default.
• W3087124500 creator A5039172101 @default.
• W3087124500 creator A5045093699 @default.
• W3087124500 creator A5046123340 @default.
• W3087124500 creator A5066530028 @default.
• W3087124500 creator A5077606912 @default.
• W3087124500 creator A5079757338 @default.
• W3087124500 creator A5080652985 @default.
• W3087124500 date "2020-09-15" @default.
• W3087124500 modified "2023-10-16" @default.
• W3087124500 title "Y90 selective internal radiation therapy and peptide receptor radionuclide therapy for the treatment of metastatic neuroendocrine tumors: combination or not?" @default.
• W3087124500 cites W2018338654 @default.
• W3087124500 cites W2034720182 @default.
• W3087124500 cites W2065625952 @default.
• W3087124500 cites W2075638315 @default.
• W3087124500 cites W2086461903 @default.
• W3087124500 cites W2087259349 @default.
• W3087124500 cites W2160185994 @default.
• W3087124500 cites W2170707038 @default.
• W3087124500 cites W2229261843 @default.
• W3087124500 cites W2494282649 @default.
• W3087124500 cites W2573369749 @default.
• W3087124500 cites W2597464530 @default.
• W3087124500 cites W2766753888 @default.
• W3087124500 cites W2783837781 @default.
• W3087124500 cites W2789923927 @default.
• W3087124500 doi "https://doi.org/10.1097/mnm.0000000000001284" @default.
• W3087124500 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32941405" @default.
• W3087124500 hasPublicationYear "2020" @default.
• W3087124500 type Work @default.
• W3087124500 sameAs 3087124500 @default.
• W3087124500 citedByCount "4" @default.
• W3087124500 countsByYear W30871245002021 @default.
• W3087124500 countsByYear W30871245002022 @default.
• W3087124500 countsByYear W30871245002023 @default.
• W3087124500 crossrefType "journal-article" @default.
• W3087124500 hasAuthorship W3087124500A5011386737 @default.
• W3087124500 hasAuthorship W3087124500A5018467007 @default.
• W3087124500 hasAuthorship W3087124500A5039172101 @default.
• W3087124500 hasAuthorship W3087124500A5045093699 @default.
• W3087124500 hasAuthorship W3087124500A5046123340 @default.
• W3087124500 hasAuthorship W3087124500A5066530028 @default.
• W3087124500 hasAuthorship W3087124500A5077606912 @default.
• W3087124500 hasAuthorship W3087124500A5079757338 @default.
• W3087124500 hasAuthorship W3087124500A5080652985 @default.
• W3087124500 hasConcept C126322002 @default.
• W3087124500 hasConcept C143998085 @default.
• W3087124500 hasConcept C170493617 @default.
• W3087124500 hasConcept C2776999253 @default.
• W3087124500 hasConcept C2778019345 @default.
• W3087124500 hasConcept C2779185275 @default.
• W3087124500 hasConcept C2993559085 @default.
• W3087124500 hasConcept C3017732841 @default.
• W3087124500 hasConcept C509974204 @default.
• W3087124500 hasConcept C71924100 @default.
• W3087124500 hasConceptScore W3087124500C126322002 @default.
• W3087124500 hasConceptScore W3087124500C143998085 @default.
• W3087124500 hasConceptScore W3087124500C170493617 @default.
• W3087124500 hasConceptScore W3087124500C2776999253 @default.
• W3087124500 hasConceptScore W3087124500C2778019345 @default.
• W3087124500 hasConceptScore W3087124500C2779185275 @default.
• W3087124500 hasConceptScore W3087124500C2993559085 @default.
• W3087124500 hasConceptScore W3087124500C3017732841 @default.
• W3087124500 hasConceptScore W3087124500C509974204 @default.
• W3087124500 hasConceptScore W3087124500C71924100 @default.
• W3087124500 hasIssue "12" @default.
• W3087124500 hasLocation W30871245001 @default.
• W3087124500 hasOpenAccess W3087124500 @default.
• W3087124500 hasPrimaryLocation W30871245001 @default.
• W3087124500 hasRelatedWork W2086461903 @default.
• W3087124500 hasRelatedWork W2338891182 @default.
• W3087124500 hasRelatedWork W2811214224 @default.
• W3087124500 hasRelatedWork W2916877202 @default.
• W3087124500 hasRelatedWork W3087124500 @default.
• W3087124500 hasRelatedWork W3204460422 @default.
• W3087124500 hasRelatedWork W4205226072 @default.
• W3087124500 hasRelatedWork W4361887425 @default.
• W3087124500 hasRelatedWork W4361933674 @default.
• W3087124500 hasRelatedWork W828941302 @default.
• W3087124500 hasVolume "41" @default.
• W3087124500 isParatext "false" @default.
• W3087124500 isRetracted "false" @default.
• W3087124500 magId "3087124500" @default.
• W3087124500 workType "article" @default.